Brief: Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results

Eocene

17/05/2022 13:04

May 17 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED PHARMACEUTICALS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS
    * CASH AND CASH EQUIVALENTS, RESTRICTED CASH AND MARKETABLE
DEBT
SECURITIES TOTALED $28.9 MILLION AS OF MARCH 31, 2022
    * NET LOSS AMOUNTED TO $6.1 MILLION, OR $0.24 PER SHARE, FOR
THREE
MONTHS ENDED MARCH 31, 2022
    * Q1 EARNINGS PER SHARE VIEW $-0.32 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn1tQknda 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))